Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Implantable defibrillators for life threatening ventricular arrhythmias. Are more effective than antiarrhythmic drugs in selected high risk patients.

× No keyword cloud information.

11 in total

1. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation).

Authors: G Gregoratos; M D Cheitlin; A Conill; A E Epstein; C Fellows; T B Ferguson; R A Freedman; M A Hlatky; G V Naccarelli; S Saksena; R C Schlant; M J Silka; J L Ritchie; R J Gibbons; M D Cheitlin; K A Eagle; T J Gardner; R P Lewis; R A O'Rourke; T J Ryan; A Garson
Journal: J Am Coll Cardiol Date: 1998-04 Impact factor: 24.094

2. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators.

Authors: J T Bigger
Journal: N Engl J Med Date: 1997-11-27 Impact factor: 91.245

3. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators.

Authors: A J Moss; W J Hall; D S Cannom; J P Daubert; S L Higgins; H Klein; J H Levine; S Saksena; A L Waldo; D Wilber; M W Brown; M Heo
Journal: N Engl J Med Date: 1996-12-26 Impact factor: 91.245

4. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings.

Authors: M Mirowski; P R Reid; M M Mower; L Watkins; V L Gott; J F Schauble; A Langer; M S Heilman; S A Kolenik; R E Fischell; M L Weisfeldt
Journal: N Engl J Med Date: 1980-08-07 Impact factor: 91.245

5. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.

Authors:
Journal: N Engl J Med Date: 1997-11-27 Impact factor: 91.245

6. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.

Authors: G H Bardy; R Yee; W Jung
Journal: J Am Coll Cardiol Date: 1996-08 Impact factor: 24.094

7. Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors.

Authors: E F Wever; R N Hauer; F L van Capelle; J G Tijssen; H J Crijns; A Algra; A C Wiesfeld; P F Bakker; E O Robles de Medina
Journal: Circulation Date: 1995-04-15 Impact factor: 29.690

8. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.

Authors: J W Mason
Journal: N Engl J Med Date: 1993-08-12 Impact factor: 91.245

3. Primary prevention of fatal ventricular arrhythmias with implantable cardioverter-defibrillator therapy--an analysis of implications based on MADIT II criteria.

Authors: Zia I Carrim; Ashraf A Khan; Shazad Aslam
Journal: Mcgill J Med Date: 2006-01

3 in total

Implantable defibrillators for life threatening ventricular arrhythmias. Are more effective than antiarrhythmic drugs in selected high risk patients.

1. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation).

2. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators.

3. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators.

4. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings.

5. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.

6. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.

7. Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors.

8. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.

9. Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). The CASCADE Investigators.

10. Resuscitation from out-of-hospital ventricular fibrillation: 4 years follow-up.

1. Audit of implantable cardioverter-defibrillators in a single UK centre.

Review 2. Implantable cardioverter-defibrillators in arrhythmias: a rapid and systematic review of effectiveness.

3. Primary prevention of fatal ventricular arrhythmias with implantable cardioverter-defibrillator therapy--an analysis of implications based on MADIT II criteria.